Therapies to Address the Symptom Burden of Huntington Disease Karen E. Anderson, MD

https://reference.medscape.com/viewarticle/huntingtons-disease-adults-treatment-impact-2026a1000hvu Huntington disease (HD) is a fatal, autosomal dominant, neurodegenerative disorder affecting neurologic, cognitive, and psychiatric function. Chorea, a debilitating symptom of HD, can be improved by vesicular monoamine transporter 2 (VMAT2) inhibitor therapy, says Dr Karen E. Anderson of Georgetown University School of Medicine in Washington, DC.